Mayinglong Pharmaceutical Group Co Ltd (600993) — Strategic Asset Allocation Index
Mayinglong Pharmaceutical Group Co Ltd (600993) has a Strategic Asset Allocation Index of 14.1% as of June 2023. Strategic assets (PP&E of CN¥523.54 Million plus long-term investments of CN¥-) total CN¥523.54 Million, measured against net assets of CN¥3.72 Billion. A higher index reflects capital-intensive or investment-heavy strategies where strategic assets dominate the equity base. See Mayinglong Pharmaceutical Group Co Ltd (600993) net asset quality to measure how much of total assets are equity-financed.
SAAI
Strategic Assets
PP&E
Net Assets
Mayinglong Pharmaceutical Group Co Ltd Strategic Asset Allocation Index (2001–2021)
This chart shows how Mayinglong Pharmaceutical Group Co Ltd's Strategic Asset Allocation Index has evolved across 21 annual periods from 2001 to 2021. As of June 2023, the index stands at 14.1%, representing strategic assets of CN¥523.54 Million against net assets of CN¥3.72 Billion CNY. For live market cap and overall valuation, see market value of Mayinglong Pharmaceutical Group Co Ltd.
Annual Strategic Asset Allocation Index for Mayinglong Pharmaceutical Group Co Ltd (2001–2021)
The table below presents the year-by-year Strategic Asset Allocation Index for Mayinglong Pharmaceutical Group Co Ltd from 2001 to 2021, covering 21 annual filings. Each row shows PP&E, long-term investments, strategic assets combined, net assets, the index percentage, and the change in percentage points compared to the prior year. See Mayinglong Pharmaceutical Group Co Ltd book value and equity for net asset value and shareholders' equity analysis.
| Year | SAAI | Strategic Assets (CNY) | PP&E | LT Investments | Net Assets | Change (pp) |
|---|---|---|---|---|---|---|
| 2021 | 13.3% | CN¥440.44 Million | CN¥440.44 Million | CN¥- | CN¥3.31 Billion | ▲ +1.6 pp |
| 2020 | 11.7% | CN¥344.06 Million | CN¥344.06 Million | CN¥- | CN¥2.95 Billion | ▼ -0.1 pp |
| 2019 | 11.7% | CN¥309.19 Million | CN¥309.19 Million | CN¥- | CN¥2.63 Billion | ▼ -10.8 pp |
| 2018 | 22.6% | CN¥530.36 Million | CN¥323.75 Million | CN¥206.61 Million | CN¥2.35 Billion | ▼ -1.1 pp |
| 2017 | 23.6% | CN¥536.31 Million | CN¥345.09 Million | CN¥191.22 Million | CN¥2.27 Billion | ▼ -5.2 pp |
| 2016 | 28.9% | CN¥582.00 Million | CN¥386.61 Million | CN¥195.39 Million | CN¥2.02 Billion | ▼ -0.3 pp |
| 2015 | 29.2% | CN¥550.87 Million | CN¥407.43 Million | CN¥143.44 Million | CN¥1.89 Billion | ▲ +11.1 pp |
| 2014 | 18.1% | CN¥307.75 Million | CN¥307.75 Million | CN¥- | CN¥1.70 Billion | ▼ 0.0 pp |
| 2013 | 18.1% | CN¥284.24 Million | CN¥284.24 Million | CN¥- | CN¥1.57 Billion | ▲ +1.5 pp |
| 2012 | 16.7% | CN¥239.26 Million | CN¥239.26 Million | CN¥- | CN¥1.43 Billion | ▼ -4.3 pp |
| 2011 | 21.0% | CN¥277.05 Million | CN¥277.05 Million | CN¥- | CN¥1.32 Billion | ▼ -2.6 pp |
| 2010 | 23.5% | CN¥265.44 Million | CN¥265.44 Million | CN¥- | CN¥1.13 Billion | ▼ -0.4 pp |
| 2009 | 24.0% | CN¥251.98 Million | CN¥251.98 Million | CN¥- | CN¥1.05 Billion | ▼ -3.2 pp |
| 2008 | 27.2% | CN¥237.11 Million | CN¥237.11 Million | CN¥- | CN¥871.43 Million | ▼ -1.3 pp |
| 2007 | 28.5% | CN¥242.94 Million | CN¥242.94 Million | CN¥- | CN¥853.12 Million | ▲ +5.3 pp |
| 2006 | 23.2% | CN¥198.05 Million | CN¥198.05 Million | CN¥- | CN¥855.21 Million | ▼ -2.1 pp |
| 2005 | 25.3% | CN¥150.71 Million | CN¥150.71 Million | CN¥- | CN¥596.55 Million | ▲ +0.5 pp |
| 2004 | 24.7% | CN¥136.59 Million | CN¥136.59 Million | CN¥- | CN¥552.20 Million | ▼ -29.0 pp |
| 2003 | 53.8% | CN¥124.38 Million | CN¥124.38 Million | CN¥- | CN¥231.35 Million | ▼ -5.0 pp |
| 2002 | 58.8% | CN¥120.23 Million | CN¥120.23 Million | CN¥- | CN¥204.54 Million | ▼ -14.5 pp |
| 2001 | 73.3% | CN¥126.00 Million | CN¥126.00 Million | CN¥- | CN¥172.01 Million | — |